- UroToday Home
- Recent Abstracts
- Urologic Oncology
Investigative Urology
A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: A prospective study - Abstract
October 20, 2012
Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: A prospective, two-stage study - Abstract
October 20, 2012
Expression changes in the stroma of prostate cancer predict subsequent relapse - Abstract
October 19, 2012
In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147 - Abstract
October 19, 2012
Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer - Abstract
October 19, 2012
The preventative effects of sunitinib malate observed in the course from non-castration to castration LNCaP xenograft prostate tumors - Abstract
October 19, 2012
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: Preliminary results - Abstract
October 18, 2012
Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer - Abstract
October 18, 2012
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B - Abstract
October 18, 2012
The desmosomal armadillo protein plakoglobin regulates prostate cancer cell adhesion and motility through vitronectin-dependent Src signaling - Abstract
October 17, 2012
TMPRSS2- driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulation - Abstract
October 17, 2012
Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence - Abstract
October 17, 2012